Evidence map›Paper›PMID 29743801›Full record

ArticleJournal of clinical and experimental hepatology2018

Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.

Sunil Taneja, Pramod Kumar, Suvradeep Mitra, Ajay Duseja, Ranjana Minz, Ashim Das, Radha K Dhiman, Yogesh Chawla

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical and experimental hepatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sunil TanejaDepartment of Hepatology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Pramod KumarDepartment of Hepatology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Suvradeep MitraDepartment of Histopathology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Ajay DusejaDepartment of Hepatology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Ranjana MinzDepartment of Immunopathology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Ashim DasDepartment of Histopathology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Radha K DhimanDepartment of Hepatology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Yogesh ChawlaDepartment of Hepatology, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute exacerbation of Autoimmune Hepatitis (AIH) poses a significant challenge for diagnosis as it can mimic acute viral hepatitis especially in absence of autoantibodies and hypergammaglobulinemia.

aimTo determine the clinical, laboratory, histopathological characteristics and response to treatment in AIH patients with acute exacerbation.

methodsA retrospective analysis of 16 patients with acute exacerbation of AIH diagnosed over a period of eight years (2008-2016).

resultsOut of the 111 patients diagnosed with AIH, acute exacerbation of AIH was diagnosed in 16 (14.4%) patients. All patients were females with median age of 35 years. Nine patients (56%) had Type 1 AIH and seven (44%) patients were diagnosed with seronegative AIH. All 16 (100%) patients had acute viral hepatitis like illness at presentation. The median bilirubin was 4.2 mg/dl (range, 2.2-20), aspartate transaminase was 568 IU/L (range, 390-908), alanine transaminase was 430 IU/L (range, 257-1026) and serum alkaline phosphatase was 395 IU/L (range, 112-890) during symptomatic period. The histopathological examination showed underlying chronic hepatitis in 10 (71.4%) patients, only fibrosis in 2 (14.2) patients and cirrhosis with activity in 2 (14.2%). All 16 (100%) patients were treated with a combination of steroids and azathioprine. Thirteen (81%) patients achieved complete biochemical remission and three (19%) patients achieved partial remission out of which one (6%) patient succumbed to illness because of the complications of cirrhosis.

conclusionA suspicion of acute exacerbation of AIH should be considered in patients with unexplained acute hepatitis mimicking acute viral hepatitis in the absence of positive viral markers. Through evaluation with immunoserological markers and liver biopsy can clinch the diagnosis of acute exacerbation of AIH in such cases.

Indexed as

AASLD, American Association of Study of Liveracute exacerbationAIH, Autoimmune HepatitisALKM-1, Liver/Kidney MicrosomesALT, Alanine TransaminaseAMA, Antimitochondrial AntibodyANA, Antinuclear AntibodiesANCA, Anti-neutrophil Cytoplasmic AntibodyASMA, Anti-smooth Muscle AntibodiesAST, Aspartate Transaminaseautoimmune hepatitisCBR, Complete Biochemical ResponseCT, Computed TomographyELISA, Enzyme-linked Immunosorbent AssayIAIHG, International Autoimmune Hepatitis GroupIIF, Indirect ImmunofluorescenceINR, International Normalized RatioMRCP, Magnetic Response CholangiopancreatographyPBC, Primary Biliary CirrhosisPBR, Partial Biochemical Responseprimary biliary cirrhosisprimary sclerosing cholangitisPSC, Primary Sclerosing CholangitisSAP, Serum Alkaline Phosphatase

Identifiers

PMID29743801
PMCPMC5938335
OpenAlexW2750968258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.